Growth after pediatric kidney transplantation: a 25-year study in a pediatric kidney transplant center

Ana Raquel Claro1, Ana Rita Oliveira2, Filipa Durão3,4

  • 1Departamento de Pediatria, 218728 Hospital de Santa Maria - Centro Hospitalar Universitário de Lisboa Norte, EPE , Lisboa, Portugal.

Insights

Pediatric kidney transplant (KT) patients show catch-up growth, but final height remains suboptimal. Glomerular filtration rate (GFR) post-KT impacts growth, highlighting areas for improved post-transplant care strategies.

Area of Science:

  • Pediatric Nephrology
  • Transplantation Medicine
  • Growth and Development

Background:

  • Growth failure is a significant complication in pediatric chronic kidney disease (CKD).
  • Up to 50% of children do not achieve their expected final height even after kidney transplant (KT).

Purpose of the Study:

  • To assess longitudinal growth patterns in children following KT.
  • To identify key factors influencing growth outcomes after pediatric KT.

Main Methods:

  • Retrospective observational study of 149 pediatric patients undergoing KT over 25 years.
  • Analysis of height and BMI z-scores at multiple time points pre- and post-KT, including transition to adult care.
  • Evaluation of factors such as target height, dialysis history, growth hormone use, GFR, and corticosteroid dose.

Main Results:

  • Patients demonstrated significant catch-up growth in height z-scores at 6 months, 1 year, 5 years post-KT, and at transition to adult care.
  • Body Mass Index (BMI) z-scores also showed significant increases post-KT.
  • Post-transplant Glomerular Filtration Rate (GFR) was significantly associated with both height and BMI z-scores.

Conclusions:

  • While catch-up growth is observed post-KT, final height remains below target in many pediatric patients.
  • Optimizing post-transplant GFR and other factors is crucial for improving final height outcomes in children after KT.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...